Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

FRA:QIA - NL0015002CX3 - Common Stock

42.55 EUR
-0.03 (-0.07%)
Last: 8/22/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, QIA scores 6 out of 10 in our fundamental rating. QIA was compared to 17 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA has a decent growth rate and is not valued too expensively. This makes QIA very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year QIA was profitable.
QIA had a positive operating cash flow in the past year.
In the past 5 years QIA has always been profitable.
Each year in the past 5 years QIA had a positive operating cash flow.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of QIA (6.41%) is better than 82.35% of its industry peers.
QIA has a Return On Equity of 10.65%. This is amongst the best in the industry. QIA outperforms 82.35% of its industry peers.
QIA has a better Return On Invested Capital (8.51%) than 70.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is in line with the industry average of 7.23%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(8.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROIC 8.51%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

QIA has a better Profit Margin (18.30%) than 94.12% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.40%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA's Operating Margin has improved in the last couple of years.
QIA's Gross Margin of 63.73% is amongst the best of the industry. QIA outperforms 94.12% of its industry peers.
QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.4%
PM (TTM) 18.3%
GM 63.73%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

QIA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, QIA has less shares outstanding
Compared to 5 years ago, QIA has less shares outstanding
The debt/assets ratio for QIA has been reduced compared to a year ago.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

QIA has an Altman-Z score of 4.18. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.18, QIA belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
The Debt to FCF ratio of QIA is 2.91, which is a good value as it means it would take QIA, 2.91 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of QIA (2.91) is better than 82.35% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that QIA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.25, QIA belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Altman-Z 4.18
ROIC/WACC1.15
WACC7.43%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.61 indicates that QIA should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.61, QIA is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
QIA has a Quick Ratio of 1.35. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
QIA has a better Quick ratio (1.35) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.35
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.05%, which is quite good.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.25% yearly.
Looking at the last year, QIA shows a small growth in Revenue. The Revenue has grown by 5.15% in the last year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)13.05%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%9.09%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%

3.2 Future

The Earnings Per Share is expected to grow by 8.18% on average over the next years. This is quite good.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y8.56%
EPS Next 2Y8.59%
EPS Next 3Y8.95%
EPS Next 5Y8.18%
Revenue Next Year4.31%
Revenue Next 2Y5%
Revenue Next 3Y5.65%
Revenue Next 5Y7.38%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.06, which indicates a rather expensive current valuation of QIA.
76.47% of the companies in the same industry are more expensive than QIA, based on the Price/Earnings ratio.
QIA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 19.04, which indicates a rather expensive current valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
QIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 21.06
Fwd PE 19.04
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as QIA.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 64.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.62
EV/EBITDA 15.12
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.46
PEG (5Y)2.55
EPS Next 2Y8.59%
EPS Next 3Y8.95%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.51%, QIA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.70, QIA has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, QIA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.51%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y8.59%
EPS Next 3Y8.95%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (8/22/2025, 7:00:00 PM)

42.55

-0.03 (-0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-07 2025-11-07/amc
Inst Owners87.24%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap9.21B
Analysts76.67
Price Target44.23 (3.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.51%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.14%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)5.26%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)0.74%
PT rev (3m)-1.27%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-0.22%
EPS NY rev (1m)0%
EPS NY rev (3m)2.52%
Revenue NQ rev (1m)1.72%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 21.06
Fwd PE 19.04
P/S 5.26
P/FCF 21.62
P/OCF 15.89
P/B 3.06
P/tB 16.78
EV/EBITDA 15.12
EPS(TTM)2.02
EY4.75%
EPS(NY)2.24
Fwd EY5.25%
FCF(TTM)1.97
FCFY4.62%
OCF(TTM)2.68
OCFY6.29%
SpS8.09
BVpS13.91
TBVpS2.54
PEG (NY)2.46
PEG (5Y)2.55
Profitability
Industry RankSector Rank
ROA 6.41%
ROE 10.65%
ROCE 11.47%
ROIC 8.51%
ROICexc 10.68%
ROICexgc 45.66%
OM 26.4%
PM (TTM) 18.3%
GM 63.73%
FCFM 24.31%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.91
Debt/EBITDA 1.22
Cap/Depr 94.78%
Cap/Sales 8.78%
Interest Coverage 250
Cash Conversion 92.78%
Profit Quality 132.83%
Current Ratio 1.61
Quick Ratio 1.35
Altman-Z 4.18
F-Score8
WACC7.43%
ROIC/WACC1.15
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)13.05%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%9.09%
EPS Next Y8.56%
EPS Next 2Y8.59%
EPS Next 3Y8.95%
EPS Next 5Y8.18%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year4.31%
Revenue Next 2Y5%
Revenue Next 3Y5.65%
Revenue Next 5Y7.38%
EBIT growth 1Y19.77%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.62%
EBIT Next 5Y14.77%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%